wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55375458-0BA45237-B136-4A88-B21E-F52ADD76E263
Q55375458-0BA45237-B136-4A88-B21E-F52ADD76E263
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55375458-0BA45237-B136-4A88-B21E-F52ADD76E263
Do immune checkpoint inhibitors need new studies methodology?
P2860
Q55375458-0BA45237-B136-4A88-B21E-F52ADD76E263
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55375458-0BA45237-B136-4A88-B21E-F52ADD76E263
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a19f7d733900c6518e8d25de10855c3620381f9f
P2860
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.